135 related articles for article (PubMed ID: 7743513)
21. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
[TBL] [Abstract][Full Text] [Related]
22. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
Ritke MK; Allan WP; Fattman C; Gunduz NN; Yalowich JC
Mol Pharmacol; 1994 Jul; 46(1):58-66. PubMed ID: 8058057
[TBL] [Abstract][Full Text] [Related]
23. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
[TBL] [Abstract][Full Text] [Related]
24. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells.
Deffie AM; Bosman DJ; Goldenberg GJ
Cancer Res; 1989 Dec; 49(24 Pt 1):6879-82. PubMed ID: 2555055
[TBL] [Abstract][Full Text] [Related]
26. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
Mirski SE; Gerlach JH; Cole SP
Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
[TBL] [Abstract][Full Text] [Related]
27. Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals.
Turner JG; Engel R; Derderian JA; Jove R; Sullivan DM
J Cell Sci; 2004 Jun; 117(Pt 14):3061-71. PubMed ID: 15173319
[TBL] [Abstract][Full Text] [Related]
28. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
[TBL] [Abstract][Full Text] [Related]
29. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
30. Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.
Mao Y; Yu C; Hsieh TS; Nitiss JL; Liu AA; Wang H; Liu LF
Biochemistry; 1999 Aug; 38(33):10793-800. PubMed ID: 10451375
[TBL] [Abstract][Full Text] [Related]
31. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190.
Samata K; Yamagishi T; Ichihara T; Nanaumi K; Ikeda T; Ikeya H; Kuraishi A; Nakaike S; Kashiwagi K; Igarashi K
Cancer Chemother Pharmacol; 2002 Nov; 50(5):367-72. PubMed ID: 12439594
[TBL] [Abstract][Full Text] [Related]
33. Identification of a single nuclear localization signal in the C-terminal domain of an Aspergillus DNA topoisomerase II.
Kim KH; Kanbe T; Akashi T; Mizuguchi I; Kikuchi A
Mol Genet Genomics; 2002 Nov; 268(3):287-97. PubMed ID: 12436251
[TBL] [Abstract][Full Text] [Related]
34. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
35. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
36. DNA topoisomerase II alpha expression is associated with alkylating agent resistance.
Eder JP; Chan VT; Ng SW; Rizvi NA; Zacharoulis S; Teicher BA; Schnipper LE
Cancer Res; 1995 Dec; 55(24):6109-16. PubMed ID: 8521401
[TBL] [Abstract][Full Text] [Related]
37. Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions.
Zini N; Santi S; Ognibene A; Bavelloni A; Neri LM; Valmori A; Mariani E; Negri C; Astaldi-Ricotti GC; Maraldi NM
Exp Cell Res; 1994 Feb; 210(2):336-48. PubMed ID: 8299728
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cells.
Sugimoto Y; Hamada H; Tsukahara S; Noguchi K; Yamaguchi K; Sato M; Tsuruo T
Cancer Res; 1993 Jun; 53(11):2538-43. PubMed ID: 8495417
[TBL] [Abstract][Full Text] [Related]
39. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.
Hinds M; Deisseroth K; Mayes J; Altschuler E; Jansen R; Ledley FD; Zwelling LA
Cancer Res; 1991 Sep; 51(17):4729-31. PubMed ID: 1651812
[TBL] [Abstract][Full Text] [Related]
40. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
